| This report analyzes the worldwide
markets for Stem Cell Research in US$ Million. Annual
estimates and forecasts are provided for the period
2008 through 2017. The report provides separate
comprehensive analytics for the US, Europe, and Rest
of World. The report profiles 87 companies including
many key and niche players such as Advanced Cell
Technology, Inc., Athersys, Inc., BioE, Inc.,
Cellartis AB, Cryo-Cell International, Inc., Cytori
Therapeutics, Inc., ES Cell International, Gamida Cell
Ltd., Genzyme Corporation, International Stem Cell
Corporation, Mesoblast Ltd., Neuralstem, Inc.,
NeuroGeneration, Inc., Osiris Therapeutics, Inc.,
StemCells, Inc., ThermoGenesis Corp., and ViaCord,
LLC. Market data and analytics are derived from
primary and secondary research. Company profiles are
primarily based upon search engine sources in the
public domain. |
The Promise of Stem Cells
Stem cells can develop into different cell types. They
may offer a renewable source of replacement cells to treat
diseases, conditions, and disabilities.
NIH Human Embryonic Stem Cell Registry
The Registry lists human embryonic stem cell lines that
are eligible for use in NIH-funded research.
U.S. Policy on Stem Cell Research
President Obama issued Executive Order 13505, entitled "Removing Barriers to Responsible Research Involving Human Stem Cells."
